@article{JLPM3991,
author = {Wouter E. Kok},
title = {Comments on GUIDE-IT, a randomized study of natriuretic peptide-guided therapy in high-risk patients with heart failure and reduced ejection fraction},
journal = {Journal of Laboratory and Precision Medicine},
volume = {3},
number = {2},
year = {2018},
keywords = {},
abstract = {The topic of guiding therapy in heart failure patients with natriuretic peptide levels is not new: eleven trials have been performed and several meta-analyses have been published including one with individual patient data (1). The GUIDE-IT trial should have been the trial that confirmed the meta-analyses that guiding therapy with natriuretic peptides in patients with heart failure would reduce the primary endpoint of heart failure readmissions and cardiovascular mortality by 20% (2,3).},
issn = {2519-9005}, url = {https://jlpm.amegroups.org/article/view/3991}
}